| Identification | Back Directory | [Name]
Lapatinib IMpurity 8 | [CAS]
320337-48-2 | [Synonyms]
Lapatinib Desmesylethylamino Hydroxy Imp
Des(sulfonylethyl)amino Hydroxy Lapatinib
Lapatinib Desmesylethylamino Hydroxy impurity
4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-(5-hydroxymethylfuran-2-yl)quinazoline
5-[4-[[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]-2-furanmethanol
2-Furanmethanol, 5-[4-[[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]amino]-6-quinazolinyl]- | [Molecular Formula]
C26H19ClFN3O3 | [MOL File]
320337-48-2.mol | [Molecular Weight]
475.9 |
| Chemical Properties | Back Directory | [Melting point ]
>150°C (dec) | [storage temp. ]
-20°C Freezer, Under inert atmosphere | [solubility ]
DMSO (Slightly), Methanol (Slightly, Heated, Sonicated) | [form ]
Solid | [color ]
Pale Yellow to Light Yellow |
| Hazard Information | Back Directory | [Uses]
Des(sulfonylethyl)amino Hydroxy Lapatinib is a compound related to drug Lapatinib (L175808), which is a selective inhibitor of epidermal growth factor receptor (EGFR) and HER-2 tyrosine kinases. Lapatinib is used to treat breast cancer, especially metastatic breast cancer that has progressed after trastuzumab treatment and other chemotherapy. |
|
| Company Name: |
TOSUN PHARM
|
| Telephone: |
020-66392521-118 18922260391 |
| Website: |
www.toref.cn/ |
|